Studsvik divests dosimetry services

6 October 2009


Studsvik has divested its operations in personal dosimetry services to Landauer, Inc. Studsvik says the sale, which generated SEK6.5 million in capital, further strengthens the firm's focus on its main business areas.

Studsvik is the market leader in personal dosimeter services in Sweden with over 6000 people monitored. Landauer, Inc., is a US-based provider of personal dosimetry services to 1.6 million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia, Mexico and other countries.

"Landauer as a specialist operator is uniquely positioned to develop the business in the long run," says Studsvik's CEO Magnus Groth.

"We see growth potential in the Swedish radiation monitoring market,in particular new opportunities within nuclear power services, and are excited about the opportunity to acquire such a high-quality, well-run dosimetry laboratory," commented Bill Saxelby, president and CEO of Landauer.

Studsvik's personal dosimetry laboratory is the largest independent laboratory in Sweden with approximately 500 active customers. The majority of customers come from businesses related to the medical industry, such as hospitals, dentists, and veterinarians, as well as a growing base of participants in the nuclear industry. Studsvik took over the operations from the Swedish Radiation Protection Institute in 1999.


Related Articles
F4E awards ITER construction contract
Korea’s star of fusion
ITER Toroidal Field Coils Winding Packs, Spain, (Deadline 13 October 2009)
Europe reveals EUR1.4bn shortfall in ITER budget
Fraser-Nash fusion deal
Another concrete step for Iter
Davy Markham, Metalcraft and AMEC bid for ITER reactor vessel contract



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.